- Home
- USA vs BCRX Comparison
USA vs BCRX Comparison
Compare USA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- BCRX
- Stock Information
- Founded
- USA 1986
- BCRX 1986
- Country
- USA United States
- BCRX United States
- Employees
- USA N/A
- BCRX N/A
- Industry
- USA Finance Companies
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USA Finance
- BCRX Health Care
- Exchange
- USA Nasdaq
- BCRX Nasdaq
- Market Cap
- USA 1.9B
- BCRX 1.8B
- IPO Year
- USA N/A
- BCRX 1994
- Fundamental
- Price
- USA $6.49
- BCRX $7.70
- Analyst Decision
- USA
- BCRX Strong Buy
- Analyst Count
- USA 0
- BCRX 10
- Target Price
- USA N/A
- BCRX $16.70
- AVG Volume (30 Days)
- USA 880.5K
- BCRX 2.2M
- Earning Date
- USA 01-01-0001
- BCRX 11-03-2025
- Dividend Yield
- USA 9.66%
- BCRX N/A
- EPS Growth
- USA N/A
- BCRX N/A
- EPS
- USA N/A
- BCRX N/A
- Revenue
- USA N/A
- BCRX $557,506,000.00
- Revenue This Year
- USA N/A
- BCRX $41.34
- Revenue Next Year
- USA N/A
- BCRX $6.11
- P/E Ratio
- USA N/A
- BCRX N/A
- Revenue Growth
- USA N/A
- BCRX 45.85
- 52 Week Low
- USA $5.62
- BCRX $6.02
- 52 Week High
- USA $7.09
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- USA 41.22
- BCRX 31.08
- Support Level
- USA $6.46
- BCRX $7.64
- Resistance Level
- USA $6.60
- BCRX $8.13
- Average True Range (ATR)
- USA 0.07
- BCRX 0.22
- MACD
- USA -0.01
- BCRX -0.05
- Stochastic Oscillator
- USA 16.67
- BCRX 6.19
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.